InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.35
(
-0.05%
)
Bitcoin
61,133.20
(
-0.51%
)
Post# of 22
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

delerious1

Send PM Follow Ignore
Followers 38
Posts 7805
Boards Moderated 2
Alias Born 11/14/2019

delerious1

Member Level

Re: None

Sunday, 09/18/2022 1:26:01 PM

Sunday, September 18, 2022 1:26:01 PM

Post# of 22
Generated Nitric Oxide

"Interpretation
Use of NONS ( Nitric Oxide Nasal Spray) in patients recently infected with SARS-CoV-2 accelerates nasal virus clearance.
A randomized, double-blind, multicentre, parallel group, placebo-controlled phase III clinical trial evaluated the ability of nitric oxide (NO) to rapidly eradicate nasal SARS-CoV-2 RNA. "

Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal
PRNE_Glenmark_Logo
NEWS PROVIDED BY

Glenmark Pharmaceuticals Ltd.
13 Jul, 2022, 16:43 IST

https://www.prnewswire.com/in/news-releases/glenmark-pharmaceuticals-and-sanotize-announce-peer-reviewed-publication-of-its-phase-3-clinical-trials-on-sanotize-s-novel-nitric-oxide-nasal-spray-for-covid-19-in-lancet-journal-882697493.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up